OR WAIT null SECS
December 13, 2021
Deal expands pharma giant’s influence in inflammation and immunology markets
December 10, 2021
The $17.4-billion deal, CDMO says, will help expand its offerings in the clinical development space
December 09, 2021
Via investment partnership with Taishin Holdings, will begin offering manufacturing services in C> space
December 06, 2021
Upon deal completion, group will acquire company’s oncology product portfolio for $846 million
December 03, 2021
CDMO’s financial commitment will feature construction of a new GMP clinical trial development facility
December 02, 2021
Financial commitment is predicted to more than double the biopharma site’s manufacturing capabilities
December 01, 2021
Transaction expands CDMO’s services, including more solutions surrounding commercial manufacturing
November 30, 2021
Five-year deal covers manufacturing of molecules, ranging from monoclonal antibodies to antibody-drug conjugates
November 29, 2021
Subject to regulatory approval, CDMO will produce mRNA vaccine on a commercial scale
November 24, 2021
The Discovery Centre will be powered by AI technology, robotics, among other features